Monograph Details
|
|
Gastrointestinal Tract
> Nausea
|
|
TRANSDERM SCOP |
| Manufacturer |
|
Novartis Consumer Health |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Anticholinergic. |
| Generic Name |
|
Scopolamine 1.5mg (delivers approximately 1mg over 3 days); transdermal patch. |
| Indications |
|
Prevention of motion sickness and post-op nausea and vomiting. |
| Children |
|
Not recommended. |
| Adults |
|
Apply to dry skin behind ear; do not cut patch. Motion sickness: 1 patch at least 4 hours before travel; remove after 72 hours. Post-op: 1 patch evening before surgery; for cesarean section: 1 patch 1 hour before surgery. Remove 24 hours after surgery. |
| Contraindications |
|
Narrow angle glaucoma. Allergy to belladonna alkaloids. |
| Precautions |
|
Wash hands and skin after use; avoid eyes. GI or urinary tract obstruction. Hepatic, renal, or metabolic dysfunction. Seizure. Psychosis. Elderly. Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Alcohol, other CNS depressants potentiate CNS depression. Additive anticholinergic effects with other anticholinergics, antihistamines (e.g., meclizine), antidepressants. May affect absorption of other drugs. |
| Adverse Reactions |
|
Dry mouth, drowsiness, blurred vision, disorientation, confusion, difficulty urination; withdrawal symptoms may occur if used for >3 days. |
| How Supplied |
|
Patches—4 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
